Belite Bio Inc ADR
Biotechnology
Healthcare
BLTE
32.08 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
71.30
52 week high
83.66
high
72.60
52 week low
0.00
low
70.06
growth
46.68 %
previous Close
71.29
P/E ratio
market cap
2.39 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-16.32 M
-14.31 %
eps
0.00 %
-11.11 %
eps surprise
-28.87 %
net profit margin
-1632000000.00 %
0.00 %
operating incoming
-17.60 M
-13.40 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top